eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hyperparathyroidism |
| Comorbidity | C0005940|bone disease |
| Sentences | 9 |
| PubMedID- 20553296 | Even when renal replacement therapy is reached, more than half patients die, mainly for cv causes due either to uremia-related cardiovascular risk factors (such as anemia, hyperhomocysteinemia, mineral bone disease-ckd with hyperparathyroidism, oxidative stress, hypoalbuminemia, chronic inflammation, prothrombotic factors) or to traditional ones (age, male gender, diabetes, obesity, hypertension, smoking, insulin levels, family history, dyslipidemia). |
| PubMedID- 23961249 | Metabolic bone disease due to hyperparathyroidism is characterized by increased bone resorption and new bone formation. |
| PubMedID- 22523515 | These findings suggest that oxc treatment leads to secondary hyperparathyroidism with high-turnover bone disease and/or impaired intestinal calcium absorption. |
| PubMedID- 24519437 | Objective: the study aimed to investigate the incidence of bone uptake of tracer on tc-99m mibi imaging and explore its influencing factors and significance for diagnosis of metabolic bone disease (mbd) in patients with hyperparathyroidism (hpt). |
| PubMedID- 20381437 | [primary hyperparathyroidism in a patient with paget's bone disease]. |
| PubMedID- 22779065 | In end-stage kidney disease patients, secondary hyperparathyroidism is associated with renal bone disease as well as with increased cardiovascular morbidity and mortality [37, 38]. |
| PubMedID- 24348080 | Before the introduction of routine measurements of serum calcium in ambulatory services, phtp (primary hyperparathyroidism) was symptomatic with classic bone disease (known as osteitis fibrosa cystica) nephrolithiasis, and acute neuropsychiatric syndrome with severe hypercalcemia. |
| PubMedID- 22620673 | We elected to use cholecalciferol to try to hasten the resolution of the hyperparathyroidism because of the active bone disease. |
| PubMedID- 19736246 | Background: hyperphosphataemia in patients on haemodialysis (hd) can lead to, or worsen, secondary hyperparathyroidism (with associated bone disease) and extra-skeletal calcifications associated with increased cardiovascular morbidity and mortality. |
Page: 1